Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM

K-Number: K031641 · 2003-08-01

ApplicantVascular Architects, Inc.
Decision Date2003-08-01
Product CodeJCT
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Vascular Architects, Inc.. It received FDA 510(k) clearance on 2003-08-01 under 510(k) number K031641. The device is classified under product code JCT. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM?

VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM is a medical device that received FDA 510(k) clearance on 2003-08-01. The listed applicant is Vascular Architects, Inc.. The 510(k) number is K031641.

When did VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM receive FDA 510(k) clearance?

VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM received FDA 510(k) clearance on 2003-08-01, under 510(k) number K031641.

Who is the listed applicant for VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM?

The FDA 510(k) record lists Vascular Architects, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM?

The FDA product code for VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM is JCT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Vascular Architects, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K030567MODIFICATION TO VASCULAR ARCHITECTS ASPIRE COVERED STENT AND CONTRILLED EXPANSION DELIVERY SYSTEMK012544VASCULAR ARCHITECTS ASPIRE COVERED STENT AND CONTROLLED EXPANSION DELIVERY SYSTEMK003173ASPIRE COVERED STENT AND DELIVERY CATHETERK003719VASCULAR ARCHITECTS PERISCOPE DEVICE

Related Devices (Code: JCT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K230269Ultraflex™ Tracheobronchial Stent SystemBoston Scientific CorporationK220424Through the Scope Tracheal Stent SystemMicro-Tech (Nanjing) Co., Ltd.K212403Tracheal Stent System (Y-Shaped)Micro-Tech (Nanjing) Co., Ltd.K202204Tracheal Stent SystemMicro-Tech (Nanjing) Co., Ltd.K201342HANAROSTENT Trachea/Bronchium (CCC)M.I.Tech Co., Ltd.K181200AEROmini Tracheobronchial Stent SystemMerit Medical Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑